Disease Markers / 2016 / Article / Tab 2

Research Article

Plasma Brain-Derived Neurotrophic Factor as a Biomarker for the Main Types of Mild Neurocognitive Disorders and Treatment Efficacy: A Preliminary Study

Table 2

Plasma BDNF levels (mean ± SD) in comparison groups at baseline, pg/mL.

Comparison groups value
WCI ( = 16)MNCD-AD
( = 21)
ScVMNCD
( = 22)
WCI versus MNCD-ADWCI versus ScVMNCDMNCD-AD versus ScVMNCD

31581.5 ± 8092.219950.7 ± 9678.825939.6 ± 10410.50.00250.210.13

: number of patients.
according to post hoc Scheffe test.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.